The Emerging Leaders collection welcomes and recognizes new talent in the oncology field. This collection acknowledges groundbreaking researchers, clinicians, and educators who are still in the early stages of their scientific careers. It serves as a platform to showcase Emerging Leaders and their exciting work in the field of supportive care in cancer. Please see our Emerging Leaders in Supportive Care in Cancer collection here (this opens in a new tab).
Dr Hannah Wardill (PhD) is the Program Lead for Supportive Oncology at South Australia’s flagship medical research institute, SAHMRI. In this role she has established and sustained a highly active research group, conducting both preclinical and clinical trials to predict, prevent and manage the symptoms and side effects of cancer therapy, with a particular focus on the gut microbiome. Dr Wardill has carved a strong reputation in supportive oncology, publishing >90 peer-reviewed articles in top tier journals such as the Journal of Clinical Oncology and attracting over $12M in competitive funding. In recognition of her leadership, excellence and advocacy, she has been appointed to the MASCC Board, named the 2023 MASCC Emerging Investigator and the Qiagen Global Microbiome Award recipient.
